Patents/Assignees

K2B Therapeutics, Inc.

1 patent in portfolio

US12534732utility2026
Therapeutic Compounds for Red Blood Cell-mediated Delivery of an Active Pharmaceutical Ingredient to a Target Cell
0 cites